Introduction
General pharmacology studies the actions of drugs on multiple systems of the body, pharmacodynamics, and how the body responds to those drugs, which is called pharmacokinetics.1
Neuropharmacology, on the other hand, focuses specifically on the pharmacological actions that involve the nervous system. It forms a bridge between general pharmacology and systems pharmacology, exploring how drugs affect the brain, spinal cord, and the neural networks that control behaviour and body function.2
Divisions of neuropharmacology: a multidisciplinary science
Neuropharmacology is multidisciplinary in nature. This means that different types of biological sciences can be discussed under it. Neuropharmacology is primarily divided into two areas:3
- Behavioural neuropharmacology: This field studies how drugs influence behaviour through their effects on neurons, the brain, and the spinal cord3
- Molecular neuropharmacology: This focuses on how drugs act at the cellular and molecular levels within the nervous system3
However, neuropharmacology also overlaps with many related disciplines, including:4
- Neuroscience: Examines the anatomy and functions of the nervous system, including the forebrain, amygdala, hippocampus, medulla, midbrain, and spinal cord
- Cellular biology: Studies biological processes at the cellular level, such as neurotransmitter production, hormone synthesis, and intercellular communication
- Bioinformatics: Applies computational methods to visualise receptor signalling, gene expression, and biochemical interactions
- Psychology: Explores behaviour and mental processes, including cognition, emotions, depression, anxiety, and decision-making
The role of neurons in neuropharmacology
Nerve cells, known as neurons, play a crucial role in neuropharmacology through their synaptic transmission. They communicate through chemical messengers called neurotransmitters, which are vital for processes such as memory formation, digestion, and excretion.5
Even small changes in neurotransmitter levels can cause major neurological or psychological disorders. Their synthesis, storage, release, and reuptake can be disrupted in diseases such as Alzheimer’s, Parkinson’s, or depression. Drugs aim to restore the balance of these neurotransmitters to maintain normal brain function.5
Neurological disorders: the importance of neuropharmacology
In today’s fast-paced, digital world, neurological conditions are increasingly common. Among them are:6
- Memory problems
- Cognitive disability
- Attention deficit
- Depression
- Unnecessary stress—anxiety
- Psychosis
- Addiction
- Convulsions
- Epileptic attacks
- Parkinsonism
Neuropharmacology in research
Wet lab studies
Researchers use animal models to study neurological diseases and test potential treatments. Examples include:7,8
- Sciatic nerve ligation for peripheral neuropathy
- Lipopolysaccharide-induced neuroinflammation
- Pilocarpine-induced epilepsy
- Paclitaxel-induced neuropathy
- Streptozocin-induced diabetes
In vitro studies
These studies use tissue samples to measure oxidative stress, inflammatory markers, and protein levels. Common techniques include:7,8
- ROS assays for reactive oxygen species
- ELISA for detecting cytokines and enzymes like COX-2
- Western blotting for protein quantification
- Flow cytometry for analysing cell populations
Dry lab tests
Data from experiments are analysed using statistical and imaging software such as:7,8
- GraphPad Prism for graphical analysis
- ImageJ for histological interpretation
- ANOVA, t-tests, and z-tests for statistical validation
Types of drugs and their neuropharmacological significance
Drugs can be classified in several ways:
By mechanism of action
How drugs interact with receptors or enzymes:
- SSRIs (e.g., fluoxetine) increase serotonin to reduce depression9
By site of action
The location where drugs act:
- Synaptic cleft: Anticholinesterases enhance acetylcholine levels10
By dosage form
How drugs are formulated:11
- Lamotrigine tablets (bipolar disorder)
- Tegretol syrup (antiepileptic)
- Lidocaine creams or gels (local anaesthetic)
- Ketamine injections (anaesthetic)
By physical state
- Solid (gabapentin)
- Liquid (diazepam for seizures)
- Semisolid (lidocaine gel)12
By target system
- Autonomic nervous system (ANS): beta-blockers (e.g., propranolol)
- Peripheral nervous system (PNS): succinylcholine (muscle relaxant)
- Central nervous system (CNS): antiepileptics13
By therapeutic use
- Anti-Parkinsonian drugs improve motor control
- Anti-Alzheimer’s agents enhance memory
- Gabapentin alleviates neuropathic pain13
By source
- Synthetic: fluoxetine
- Semi-synthetic: heroin
- Natural: morphine14
By chemical nature
- Alkaloids: morphine
- Tricyclics: antidepressants14
By targeting signal transduction
- Risperidone: dopamine receptor antagonist (schizophrenia)
- Donepezil: acetylcholinesterase inhibitor (memory loss)15
Signal transduction and drug mechanisms
Signals in the nervous system start when neurotransmitters bind to receptors on neurons. This triggers a cascade of intracellular reactions that leads to specific cellular responses.16,18
For instance, acetylcholine binds to two types of receptors:
- Nicotinic (nAChR): allows sodium and calcium influx, activating protein kinase C (PKC)
- Muscarinic (mAChR): triggers the Gq-protein pathway, activating phospholipase C (PLC), which increases intracellular calcium and further activates PKC
Activated PKC then phosphorylates target proteins such as PAK and NMDA receptors, which are essential for learning and memory.19
In disease states, acetylcholine also affects microglial cells, modulating inflammation through pathways like NF-κB and JAK-STAT, which can either suppress or promote neuroinflammation depending on the context.16,18
Neuroinflammation vs. neuropathy
Neuropathy occurs when nerves are damaged by infection, toxins, hypoxia, or diabetes. Purinergic receptors (P2X, P2Y12, P2Y4/6) are key players.20
When activated by ATP or ADP, they stimulate intracellular signalling (PI3K/Akt pathway), leading to calcium release, microglial activation, and inflammation.20
FAQs
Is there any scope for neuropharmacological experimentation?
Yes, there is a huge inclination of researchers towards neuropharmacology in the age of globalisation. We can test every type of drug after the induction of different diseases in animals like albino mice and Sprague-Dawley rats.7,8
What are the future perspectives of neuropharmacology?
Future research aims to repurpose natural and synthetic drugs, develop safer compounds, and deepen understanding of brain function.7,8
What is the core concept of neuropharmacology?
Neuropharmacology focuses on how drugs influence the nervous system—especially the brain—as the central control hub of the body. Understanding these interactions allows for targeted treatment of neurological disorders.
Summary
Neuropharmacology is the study of how drugs affect the nervous system at molecular, cellular, and behavioural levels. It plays a vital role in understanding and treating neurological disorders such as epilepsy, depression, and Alzheimer’s disease. Through experimental research involving animal models, tissue studies, and data analysis, scientists can investigate drug–receptor interactions and map out signalling pathways that control brain activity. This knowledge forms the foundation for developing safer and more effective therapies for neurological and psychiatric conditions.
References
- beemarcom_admin. Understanding pharmacokinetics & pharmacodynamics [Internet]. Alimentiv. 2023 [cited 2025 Jun 14]. Available from: https://alimentiv.com/pharmacokinetics-vs-pharmacodynamics/
- Neuropharmacology [Internet]. [cited 2025 Jun 14]. Available from: https://www.pharm.ox.ac.uk/research/themes-1/neuropharmacology
- Ali N. Basic strategy of neuropharmacology and its branches. [cited 2025 Jun 14]; Available from: https://www.ajpbp.com/ajpbp-articles/basic-strategy-of-neuropharmacology-and-its-branches-91844.html
- Neuropharmacology - an overview | sciencedirect topics [Internet]. [cited 2025 Jun 14]. Available from: https://www.sciencedirect.com/topics/neuroscience/neuropharmacology
- Sheffler ZM, Reddy V, Pillarisetty LS. Physiology, neurotransmitters. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK539894/
- Neurological disorders [Internet]. 2025 [cited 2025 Jun 14]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/neurological-disorders
- S D. Neuropharmacology: understanding the complex interplay of drugs and the nervous system. The Neurologist: Clinical & Therapeutics Journal [Internet]. 2023 May 31 [cited 2025 Jun 14];7(3):1–3. Available from: https://www.omicsonline.org/open-access/neuropharmacology-understanding-the-complex-interplay-of-drugs-andthe-nervous-system-124737.html
- ALAYLIOĞLU M, DURSUN E, YILMAZER S, AK DG. A bridge between in vitro and in vivo studies in neuroscience: organotypic brain slice cultures. Noro Psikiyatr Ars [Internet]. 2020 Sep 21 [cited 2025 Jun 14];57(4):333–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735142/
- Exploring ssris (Selective serotonin reuptake inhibitors): what you need to know | good... [Internet]. [cited 2025 Jun 14]. Available from: https://www.goodtherapy.org/drugs/antidepressants-ssris.html
- Sam C, Bordoni B. Physiology, acetylcholine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK557825/
- Drug formulation - an overview | sciencedirect topics [Internet]. [cited 2025 Jun 14]. Available from: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/drug-formulation
- BYJUS [Internet]. [cited 2025 Jun 14]. Https://byjus. Com/chemistry/classification-drugs/. Available from: https://byjus.com/chemistry/classification-drugs/
- Devanne H. Neuropharmacology: role of drugs and their effects on the nervous system. Journal of Pharmacological Reports [Internet]. 2024 Jun 25 [cited 2025 Jun 14];8(2):1–2. Available from: https://www.longdom.org/
- Choudhary A. Nature and source of drugs [Internet]. [cited 2025 Jun 14]. Available from: https://www.pharmaguideline.com/2021/09/nature-and-source-of-drugs.html
- Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia AS, McNamara JO, et al. Second messenger targets: protein kinases and phosphatases. In: Neuroscience 2nd edition [Internet]. Sinauer Associates; 2001 [cited 2025 Jun 14]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11002/
- Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol [Internet]. 2015 Jun [cited 2025 Jun 14];15(6):335–49. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786079/
- Wang K, Xie Y, Chen X, Ouyang X, Zhao L, Chen H, et al. The activation of muscarinic acetylcholine receptors protects against neuroinflammation in a mouse model through attenuating microglial inflammation. Int J Mol Sci. 2024 Sep 27;25(19):10432.
- Bye LJ, Finol-Urdaneta RK, Tae HS, Adams DJ. Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases. The International Journal of Biochemistry & Cell Biology [Internet]. 2023 Apr 1 [cited 2025 Jun 14];157:106387. Available from: https://www.sciencedirect.com/science/article/pii/S1357272523000262
- Yamahashi Y, Lin YH, Mouri A, Iwanaga S, Kawashima K, Tokumoto Y, et al. Phosphoproteomic of the acetylcholine pathway enables discovery of the PKC-β-PIX-Rac1-PAK cascade as a stimulatory signal for aversive learning. Mol Psychiatry [Internet]. 2022 Aug [cited 2025 Jun 14];27(8):3479–92. Available from: https://www.nature.com/articles/s41380-022-0
- Domercq M, Vazquez N, Matute C. Neurotransmitter signaling in the pathophysiology of microglia. Front Cell Neurosci [Internet]. 2013 Apr 19 [cited 2025 Jun 14];7. Available from: https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2013.00049/full

